bunazosin has been researched along with diltiazem in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (33.33) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
| Abiko, Y; Ichihara, K; Nasa, Y; Yoshida, R | 1 |
| Chiba, S; Skrbic, R | 1 |
| Chiba, S; Matsuura, M; Zenda, H | 1 |
| Chiba, S; Haniuda, M | 2 |
| Chiba, S; Tsukada, M | 1 |
| Geshi, E; Hiroshige, J; Katagiri, T; Konno, N; Mochizuki, M; Umetsu, K | 1 |
| Chiba, S; Ohkubo, H | 1 |
| Chiba, S; Sinanović, O | 1 |
| Chiba, S; Vhora, S | 1 |
12 other study(ies) available for bunazosin and diltiazem
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
Positive inotropic and negative chronotropic effects of (-)-cis-diltiazem in rat isolated atria.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Antagonists; Animals; Aorta, Thoracic; Atenolol; Calcium; Diltiazem; Endothelium, Vascular; Guinea Pigs; Heart Atria; Heart Rate; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Myocardial Contraction; Potassium Chloride; Quinazolines; Rats; Rats, Inbred Strains; Stereoisomerism; Verapamil | 1992 |
Pharmacological features of vascular responses of isolated dog and monkey lingual arteries to vasoactive substances.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Arteries; Diltiazem; Dogs; Dose-Response Relationship, Drug; Female; Imidazoles; In Vitro Techniques; Macaca; Male; Norepinephrine; Perfusion; Potassium Chloride; Quinazolines; Tongue; Vasoconstrictor Agents | 1991 |
Pharmacologic analysis of 7-O-ethyl-fangchinoline-induced vasodilation properties in isolated perfused common carotid arteries of Wistar Kyoto rats and spontaneously hypertensive rats.
Topics: Alkaloids; Animals; Atropine; Benzylisoquinolines; Carotid Arteries; Diltiazem; In Vitro Techniques; Isoproterenol; Male; Phenylephrine; Propranolol; Quinazolines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vasoconstriction; Vasodilation; Vasodilator Agents | 1991 |
Perfusion-time dependent enhancements of guanabenz- and KCl-induced vasoconstrictions in isolated and perfused dog pulmonary veins.
Topics: Adrenergic alpha-Antagonists; Animals; Diltiazem; Dogs; Dose-Response Relationship, Drug; Female; Guanabenz; Imidazoles; Male; Potassium Chloride; Pulmonary Veins; Quinazolines; Receptors, Adrenergic, alpha; Time Factors; Vasoconstriction | 1990 |
Predominant acetylcholine-induced vasoconstriction in isolated, perfused simian facial veins.
Topics: Acetylcholine; Adrenergic alpha-Antagonists; Animals; Atropine; Blood Pressure; Diltiazem; Face; Female; In Vitro Techniques; Macaca; Male; Muscle, Smooth, Vascular; Parasympatholytics; Physostigmine; Piperidines; Pirenzepine; Potassium Chloride; Quinazolines; Receptors, Muscarinic; Saponins; Vasoconstriction; Veins | 1990 |
Protection of acute ischemic myocardial injury by pharmacological intervention.
Topics: Adenosine Triphosphatases; Adrenergic alpha-Antagonists; Animals; Calcium; Calcium-Transporting ATPases; Coenzymes; Coronary Disease; Diltiazem; Dogs; Myocardium; Niacinamide; Nicorandil; Quinazolines; Sarcoplasmic Reticulum; Ubiquinone; Vasodilator Agents | 1989 |
Perfusion-time-dependent appearance of blocking effect of diltiazem on norepinephrine-induced vasoconstriction in isolated, perfused dog pulmonary veins.
Topics: Animals; Diltiazem; Dogs; Dose-Response Relationship, Drug; Female; Imidazoles; In Vitro Techniques; Male; Norepinephrine; Perfusion; Propranolol; Pulmonary Veins; Quinazolines; Time Factors; Vasoconstriction | 1989 |
Pharmacological analysis of vasoconstriction of isolated canine ophthalmic and ciliary arteries to alpha-adrenoceptor agonists.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Arteries; Ciliary Body; Diltiazem; Dogs; Dose-Response Relationship, Drug; Female; In Vitro Techniques; Male; Nitroprusside; Ophthalmic Artery; Quinazolines; Vasoconstriction | 1987 |
Pharmacological analysis of 5-HT-induced vasoconstriction in isolated, perfused dog skeletal muscle arteries.
Topics: Adrenergic alpha-Antagonists; Animals; Arteries; Cold Temperature; Diltiazem; Dogs; Female; In Vitro Techniques; Ketanserin; Male; Methysergide; Muscle, Smooth, Vascular; Norepinephrine; Potassium Chloride; Quinazolines; Serotonin; Vasoconstriction | 1987 |
Functional 5-HT receptor subtypes in the isolated canine common carotid artery.
Topics: Adrenergic alpha-Antagonists; Animals; Carotid Artery, Common; Diltiazem; Dogs; Female; Ketanserin; Male; Methysergide; Norepinephrine; Potassium Chloride; Quinazolines; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists; Spiperone; Vasoconstriction | 1994 |